Cargando…
Corticosteroids May Have Negative Effects on the Management of Patients with Severe Fever with Thrombocytopenia Syndrome: A Case–Control Study
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging viral hemorrhagic fever in China, Korea, and Japan. To date, no standardized treatment protocol for SFTS has been established. Corticosteroids (CS) may be administered to patients with SFTS and hemophagocytic syndrome, but its effecti...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145003/ https://www.ncbi.nlm.nih.gov/pubmed/33925061 http://dx.doi.org/10.3390/v13050785 |
_version_ | 1783697078886596608 |
---|---|
author | Kawaguchi, Takeshi Umekita, Kunihiko Yamanaka, Atsushi Hara, Seiichiro Yamaguchi, Tetsuro Inoue, Eisuke Okayama, Akihiko |
author_facet | Kawaguchi, Takeshi Umekita, Kunihiko Yamanaka, Atsushi Hara, Seiichiro Yamaguchi, Tetsuro Inoue, Eisuke Okayama, Akihiko |
author_sort | Kawaguchi, Takeshi |
collection | PubMed |
description | Severe fever with thrombocytopenia syndrome (SFTS) is an emerging viral hemorrhagic fever in China, Korea, and Japan. To date, no standardized treatment protocol for SFTS has been established. Corticosteroids (CS) may be administered to patients with SFTS and hemophagocytic syndrome, but its effectiveness and safety are still debatable. We conducted a retrospective case series review at four medical facilities in Miyazaki, Japan. Based on the medical records, clinical data, including the patients background, symptoms, physical findings, laboratory data at initial presentation, treatment, and outcome, were compared between the CS-treated and the non-CS-treated group. A total of 47 patients with confirmed SFTS in each hospital were enrolled in this study; there were 14 fatal cases and 33 nonfatal cases. The case fatality ratio was 29.8%. After adjusting patients’ background by propensity score matching, the case fatality ratio was higher (p = 0.04) and complications of secondary infections, including invasive pulmonary aspergillosis, tended to be more frequent (p = 0.07) in the CS-treated group than in the non-CS-treated group. These data suggested that administration of CS to patients with SFTS should be carefully considered. |
format | Online Article Text |
id | pubmed-8145003 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81450032021-05-26 Corticosteroids May Have Negative Effects on the Management of Patients with Severe Fever with Thrombocytopenia Syndrome: A Case–Control Study Kawaguchi, Takeshi Umekita, Kunihiko Yamanaka, Atsushi Hara, Seiichiro Yamaguchi, Tetsuro Inoue, Eisuke Okayama, Akihiko Viruses Article Severe fever with thrombocytopenia syndrome (SFTS) is an emerging viral hemorrhagic fever in China, Korea, and Japan. To date, no standardized treatment protocol for SFTS has been established. Corticosteroids (CS) may be administered to patients with SFTS and hemophagocytic syndrome, but its effectiveness and safety are still debatable. We conducted a retrospective case series review at four medical facilities in Miyazaki, Japan. Based on the medical records, clinical data, including the patients background, symptoms, physical findings, laboratory data at initial presentation, treatment, and outcome, were compared between the CS-treated and the non-CS-treated group. A total of 47 patients with confirmed SFTS in each hospital were enrolled in this study; there were 14 fatal cases and 33 nonfatal cases. The case fatality ratio was 29.8%. After adjusting patients’ background by propensity score matching, the case fatality ratio was higher (p = 0.04) and complications of secondary infections, including invasive pulmonary aspergillosis, tended to be more frequent (p = 0.07) in the CS-treated group than in the non-CS-treated group. These data suggested that administration of CS to patients with SFTS should be carefully considered. MDPI 2021-04-28 /pmc/articles/PMC8145003/ /pubmed/33925061 http://dx.doi.org/10.3390/v13050785 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kawaguchi, Takeshi Umekita, Kunihiko Yamanaka, Atsushi Hara, Seiichiro Yamaguchi, Tetsuro Inoue, Eisuke Okayama, Akihiko Corticosteroids May Have Negative Effects on the Management of Patients with Severe Fever with Thrombocytopenia Syndrome: A Case–Control Study |
title | Corticosteroids May Have Negative Effects on the Management of Patients with Severe Fever with Thrombocytopenia Syndrome: A Case–Control Study |
title_full | Corticosteroids May Have Negative Effects on the Management of Patients with Severe Fever with Thrombocytopenia Syndrome: A Case–Control Study |
title_fullStr | Corticosteroids May Have Negative Effects on the Management of Patients with Severe Fever with Thrombocytopenia Syndrome: A Case–Control Study |
title_full_unstemmed | Corticosteroids May Have Negative Effects on the Management of Patients with Severe Fever with Thrombocytopenia Syndrome: A Case–Control Study |
title_short | Corticosteroids May Have Negative Effects on the Management of Patients with Severe Fever with Thrombocytopenia Syndrome: A Case–Control Study |
title_sort | corticosteroids may have negative effects on the management of patients with severe fever with thrombocytopenia syndrome: a case–control study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145003/ https://www.ncbi.nlm.nih.gov/pubmed/33925061 http://dx.doi.org/10.3390/v13050785 |
work_keys_str_mv | AT kawaguchitakeshi corticosteroidsmayhavenegativeeffectsonthemanagementofpatientswithseverefeverwiththrombocytopeniasyndromeacasecontrolstudy AT umekitakunihiko corticosteroidsmayhavenegativeeffectsonthemanagementofpatientswithseverefeverwiththrombocytopeniasyndromeacasecontrolstudy AT yamanakaatsushi corticosteroidsmayhavenegativeeffectsonthemanagementofpatientswithseverefeverwiththrombocytopeniasyndromeacasecontrolstudy AT haraseiichiro corticosteroidsmayhavenegativeeffectsonthemanagementofpatientswithseverefeverwiththrombocytopeniasyndromeacasecontrolstudy AT yamaguchitetsuro corticosteroidsmayhavenegativeeffectsonthemanagementofpatientswithseverefeverwiththrombocytopeniasyndromeacasecontrolstudy AT inoueeisuke corticosteroidsmayhavenegativeeffectsonthemanagementofpatientswithseverefeverwiththrombocytopeniasyndromeacasecontrolstudy AT okayamaakihiko corticosteroidsmayhavenegativeeffectsonthemanagementofpatientswithseverefeverwiththrombocytopeniasyndromeacasecontrolstudy |